Supreme Court Asks for Government's View on Bayer's Roundup Case -- Market Talk

Dow Jones

06/30

1108 ET - The Supreme Court has asked the Trump administration for its view in Bayer's latest bid to challenge the Roundup weedkiller litigation that has cost it billions of dollars. Bayer's latest attempt to get the court to narrow the litigation that has dogged it for nearly a decade argues that users of Roundup can't sue it because regulators have said glyphosate, the main ingredient, doesn't require a cancer warning label. Bayer will now have to wait several more months for a decision. "We see this request as an encouraging step and look forward to hearing the views of the government," said Bayer CEO Bill Anderson in a statement. Analysts at BMO Capital Markets had given the company a 20% to 25% chance of a favorable ruling if SCOTUS requested an opinion from the solicitor general. (patrick.thomas@wsj.com)

(END) Dow Jones Newswires

June 30, 2025 11:09 ET (15:09 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2547901342"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2547901342\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2547901342?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-30 23:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2547901342","market":"sh","top_or_hot":-1,"title":"Supreme Court Asks for Government's View on Bayer's Roundup Case -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1108 ET - The Supreme Court has asked the Trump administration for its view in Bayer's latest bid to challenge the Roundup weedkiller litigation that has cost it billions of dollars. Bayer's latest attempt to get the court to narrow the litigation that has dogged it for nearly a decade argues that users of Roundup can't sue it because regulators have said glyphosate, the main ingredient, doesn't require a cancer warning label. Bayer will now have to wait several more months for a decision. \"We see this request as an encouraging step and look forward to hearing the views of the government,\" said Bayer CEO Bill Anderson in a statement. Analysts at BMO Capital Markets had given the company a 20% to 25% chance of a favorable ruling if SCOTUS requested an opinion from the solicitor general. (patrick.thomas@wsj.com) \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 30, 2025 11:09 ET (15:09 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Supreme Court Asks for Government's View on Bayer's Roundup Case -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSupreme Court Asks for Government's View on Bayer's Roundup Case -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-06-30 23:09</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1108 ET - The Supreme Court has asked the Trump administration for its view in Bayer's latest bid to challenge the Roundup weedkiller litigation that has cost it billions of dollars. Bayer's latest attempt to get the court to narrow the litigation that has dogged it for nearly a decade argues that users of Roundup can't sue it because regulators have said glyphosate, the main ingredient, doesn't require a cancer warning label. Bayer will now have to wait several more months for a decision. \"We see this request as an encouraging step and look forward to hearing the views of the government,\" said Bayer CEO Bill Anderson in a statement. Analysts at BMO Capital Markets had given the company a 20% to 25% chance of a favorable ruling if SCOTUS requested an opinion from the solicitor general. (patrick.thomas@wsj.com) \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 30, 2025 11:09 ET (15:09 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"製藥","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2547901342","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2547901342","pubTimestamp":1751296140,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1108 ET - The Supreme Court has asked the Trump administration for its view in Bayer's latest bid to challenge the Roundup weedkiller litigation that has cost it billions of dollars. Bayer's latest attempt to get the court to narrow the litigation that has dogged it for nearly a decade argues that users of Roundup can't sue it because regulators have said glyphosate, the main ingredient, doesn't require a cancer warning label. Bayer will now have to wait several more months for a decision. \"We see this request as an encouraging step and look forward to hearing the views of the government,\" said Bayer CEO Bill Anderson in a statement. Analysts at BMO Capital Markets had given the company a 20% to 25% chance of a favorable ruling if SCOTUS requested an opinion from the solicitor general. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","BAYRY":"Bayer A.G."},"translate_title":"最高法院征求政府对拜耳农达案的看法——市场谈话","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BAYRY":0.9},"content_text":"1108 ET - The Supreme Court has asked the Trump administration for its view in Bayer's latest bid to challenge the Roundup weedkiller litigation that has cost it billions of dollars. Bayer's latest attempt to get the court to narrow the litigation that has dogged it for nearly a decade argues that users of Roundup can't sue it because regulators have said glyphosate, the main ingredient, doesn't require a cancer warning label. Bayer will now have to wait several more months for a decision. \"We see this request as an encouraging step and look forward to hearing the views of the government,\" said Bayer CEO Bill Anderson in a statement. Analysts at BMO Capital Markets had given the company a 20% to 25% chance of a favorable ruling if SCOTUS requested an opinion from the solicitor general. (patrick.thomas@wsj.com) \n\n\n  (END) Dow Jones Newswires\n\n\n  June 30, 2025 11:09 ET (15:09 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}